Pharmacokinetics, safety and tolerability of the novel β‐hCG derived immunomodulatory compound, EA‐230

Eitemau Tebyg

• Immunomodulatory and Kidney-Protective Effects of the Human Chorionic Gonadotropin Derivate EA-230
  gan: van Groenendael, Roger, et al.
  Cyhoeddwyd: (2018)
• A randomized double‐blind, placebo‐controlled clinical phase IIa trial on safety, immunomodulatory effects and pharmacokinetics of EA‐230 during experimental human endotoxaemia
  gan: van Groenendael, Roger, et al.
  Cyhoeddwyd: (2019)
• The Safety, Tolerability, and Effects on the Systemic Inflammatory Response and Renal Function of the Human Chorionic Gonadotropin Hormone-Derivative EA-230 Following On-Pump Cardiac Surgery (The EASI Study): Protocol for a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
  gan: van Groenendael, Roger, et al.
  Cyhoeddwyd: (2019)
• Safety and Efficacy of Human Chorionic Gonadotropin Hormone-Derivative EA-230 in Cardiac Surgery Patients: A Randomized Double-Blind Placebo-Controlled Study
  gan: van Groenendael, Roger, et al.
  Cyhoeddwyd: (2021)
• Gender-specific differences in outcome after trauma may be explained by differences in immunity
  gan: Eijk, Lucas T van, et al.
  Cyhoeddwyd: (2014)